CT
Cyclerion Therapeutics Inc
🇺🇸XNAS.CYCNUnited StatesHealthcare
$3.36USDdown -0.85 (-20.19%)OpenEnd of day6:05 PM
Price$3.36-0.85 (-20.19%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US23255M2044
- CUSIP
- 23255M105
Company
- Employees
- 1
- Headquarters
- Cambridge, United States
- Website
- https://www.cyclerion.com
- CEO
- Dr. Regina M. Graul Ph.D.
Market
- Shares outstanding
- 668.8K
- Market cap
- $15.73M
Highlights
- Market cap
- $15.73M
- EPS LTM
- -$11.04
- P/E LTM
- -0.31
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.9M-12.6%down year on year
- Net income
- -$6.71M-244.66%down year on year
- Gross margin
- 61.58%
- Free cash flow
- -$4.45M-57.45%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.